Itamar Medical Ltd.

Itamar Medical Ltd.
Stock Exchange Other OTC
EPS
$0.01
Market Cap
$108.48 M
Shares Outstanding
259.58 M
Public Float
-

Profile

Address
9 Halamish Street
Caesarea HA 38900
Israel
Employees -
Website http://www.itamar-medical.com
Updated 07/08/2019
Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. The firm develops and markets two products, namely, WatchPAT and EndoPAT. The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease.

Financials

View All

Giora Yaron
Chairman
Christopher Michael Cleary
Director